MedTrace Logo

0.075% Capsaicin Lotion for the Treatment of Painful Diabetic Neuropathy

NCT03113448 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2018-09-12

No results posted yet for this study

Summary

To study that 0.075% capsaicin lotion is safe, well tolerated and provide significant pain relief in patients with PDN compared with placebo lotion as a randomized, double- Blind, crossover, placebo-controlled trial

Conditions

  • Peripheral Diabetic Neuropathy

Interventions

DRUG

0.075% Capsaicin Lotion

To apply 3-4 times per day, every day until 8 weeks then stop

DRUG

placebo

To apply 3-4 times per day, every day until 8 weeks then stop

Sponsors & Collaborators

  • Thammasat University

    lead OTHER

Principal Investigators

  • Kongkiat Kulkantrakorn, Professor · Thammasat University Hospital

  • Pasiri Sithinamsuwan · Phramongkutklao College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-19
Primary Completion
2017-04-21
Completion
2018-01-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03113448 on ClinicalTrials.gov